Michael Quintel Selected Research

perflubron (L 1913)

6/2010	Ventilation-perfusion ratio in perflubron during partial liquid ventilation.
9/2005	Relationship among cardiac index, inspiration/expiration ratio, and perfluorocarbon dose during partial liquid ventilation in an oleic acid model of acute lung injury in sheep.
1/2005	Comparison of different inhalational perfluorocarbons in a rabbit model of acute lung injury.
8/2003	End-expiratory lung volumes and density distribution patterns during partial liquid ventilation in healthy and oleic acid-injured sheep: a computed tomography study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Quintel Research Topics

Disease

32	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 10/2003
13	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 09/2005
12	Sepsis (Septicemia) 11/2021 - 03/2003
10	Critical Illness (Critically Ill) 01/2022 - 03/2003
9	Ventilator-Induced Lung Injury 01/2022 - 04/2006
9	Hypoxia (Hypoxemia) 12/2021 - 12/2012
8	Lung Injury 01/2019 - 08/2003
7	Wounds and Injuries (Trauma) 01/2021 - 03/2003
6	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2008
6	Body Weight (Weight, Body) 05/2018 - 01/2005
5	Acute Lung Injury 04/2013 - 01/2005
4	Infections 01/2021 - 07/2009
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 03/2013
4	Edema (Dropsy) 07/2017 - 12/2012
4	Heart Failure 08/2012 - 11/2009
3	Pulmonary Atelectasis 12/2021 - 11/2003
3	Inflammation (Inflammations) 01/2021 - 12/2012
3	Pulmonary Edema 01/2021 - 02/2004
3	Acidosis 01/2020 - 11/2011
3	Hypothermia 04/2018 - 01/2006
3	Pain (Aches) 01/2017 - 02/2016
3	Acute Kidney Injury (Acute Renal Failure) 04/2015 - 01/2011
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2007 - 10/2005
2	Cholestasis 01/2022 - 12/2021
2	Pneumonia (Pneumonitis) 10/2021 - 12/2012
2	Healthcare-Associated Pneumonia 01/2021 - 06/2015
2	Hypotension (Low Blood Pressure) 01/2020 - 01/2018
2	Rupture 01/2019 - 07/2017
2	Delirium 12/2017 - 02/2010
2	Multiple Trauma (Multiple Injuries) 10/2016 - 09/2011
2	Necrosis 09/2016 - 12/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2016 - 03/2016
2	Chronic Pain 07/2016 - 02/2016
2	Hemolysis 02/2016 - 04/2015
2	Renal Insufficiency (Renal Failure) 10/2013 - 01/2012
1	Paralysis (Palsy) 01/2022
1	COVID-19 10/2021
1	Hypercapnia 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Ventilator-Associated Pneumonia 01/2019
1	Hyperlactatemia 01/2019
1	Non-ST Elevated Myocardial Infarction 01/2018
1	Shock 01/2018

Drug/Important Bio-Agent (IBA)

5	AlbuminsIBA 01/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2020
4	perflubron (L 1913)FDA Link 06/2010 - 08/2003
4	Oleic Acid (Oleate)IBA 08/2006 - 08/2003
3	ProcalcitoninIBA 01/2021 - 09/2011
3	Carbon DioxideIBA 01/2021 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2003
3	Oxygen (Dioxygen)IBA 11/2020 - 06/2010
3	FluorocarbonsIBA 10/2010 - 01/2005
2	AcidsIBA 01/2022 - 12/2012
2	AerosolsIBA 03/2021 - 01/2013
2	AlkanesIBA 03/2021 - 10/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2015
2	CatecholaminesIBA 01/2020 - 11/2011
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2008
2	CytokinesIBA 01/2017 - 06/2014
2	Analgesics (Analgesic Drugs)IBA 07/2016 - 02/2016
2	Saline SolutionIBA 08/2006 - 01/2005
2	Surface-Active Agents (Surfactants)IBA 12/2003 - 11/2003
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Drug CarriersIBA 03/2021
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	Crystalloid SolutionsIBA 01/2021
1	SodiumIBA 01/2021
1	ElectrolytesIBA 01/2021
1	Troponin T (Troponin T1)IBA 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020
1	pro-brain natriuretic peptide (1-76)IBA 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	InterferonsIBA 01/2020
1	Neuromuscular Blocking AgentsIBA 01/2020
1	Volatile Organic CompoundsIBA 01/2019
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 05/2018
1	Third Generation CephalosporinsIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	FluoroquinolonesIBA 01/2018

Therapy/Procedure

23	Therapeutics 12/2021 - 02/2005
16	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2005
14	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2021 - 08/2003
12	Critical Care (Surgical Intensive Care) 01/2021 - 02/2004
10	Extracorporeal Membrane Oxygenation 12/2021 - 02/2005
8	Mechanical Ventilators (Ventilator) 01/2020 - 01/2009
3	Anesthesia 01/2022 - 01/2007
3	Noninvasive Ventilation 10/2021 - 05/2012
3	Resuscitation 12/2020 - 05/2014
3	Catheters 04/2018 - 03/2013
3	Liquid Ventilation 10/2010 - 10/2003
2	Length of Stay 04/2018 - 01/2006
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2017 - 02/2016
2	Heart-Assist Devices 11/2010 - 11/2009
1	Continuous Positive Airway Pressure 10/2021
1	Conduction Anesthesia (Regional Anesthesia) 04/2018
1	Epidural Anesthesia 04/2018
1	General Anesthesia 04/2018
1	Thoracotomy 04/2018
1	Percutaneous Coronary Intervention 01/2018